News

THE WORLD’S TWO BEST SCIENTIFIC INSTITUTES CALL PALM BEACH COUNTY HOME

May 16, 2019, JUPITER, FL – Nature Index has ranked Max Planck Society and Scripps Research as the world’s top two stand-alone scientific institutes for biomedical research. In fact, Florida Atlantic University’s Jupiter, FL, campus is the only place on the planet where two quality research institutions are co-located.  Nature Index, the definitive ranking source for research institutions, based these results on high impact papers and yearly growth over the past five years.  Along with Florida Atlantic University, a Nikon Center of Excellence, these three institutions form an unparalleled research campus for biomedical research.

MORE “THE WORLD’S TWO BEST SCIENTIFIC INSTITUTES CALL PALM BEACH COUNTY HOME”

BDB SBIR WORKSHOP FUELS SUCCESS FOR LOCAL ENTREPRENEUR

Last year, the Business Development Board of Palm Beach County (BDB), in collaboration with a group of local entrepreneurial support organizations including FAU Tech Runway, Palm Beach Tech, Small Business Development Center, and the Research Park, brought the Small Business Innovation Research (SBIR) program to Palm Beach County, a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. This workshop supported the growth of home-grown life sciences start-ups and one of the success stories is SciKey Diagnostics.

MORE “BDB SBIR WORKSHOP FUELS SUCCESS FOR LOCAL ENTREPRENEUR”

TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men

BOCA RATON, Fla.–(BUSINESS WIRE)–May 6, 2019– TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the presentation of results from the Men’s Attitude Toward Menopause Survey (MATE), a large study of men’s understanding of and attitudes related to menopause, at the American College of Obstetricians and Gynecologists 2019 Annual Meeting. The data, representing insights collected from 450 men married to and living with women of menopausal age, uncovered men’s perceptions and attitudes towards menopause and their role in their partner’s menopausal transition.

MORE “TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men”

RSM Announces Strategic Partnership with Technology and Life Sciences Accelerator, OCTANe

RSM US LLP (“RSM”) – the nation’s leading provider of audit, tax and consulting services focused on the middle market – today announced a strategic partnership with OCTANe, a technology and life sciences accelerator based in Orange County, California. The goal of the partnership is to drive further innovation, and fuel the growth of companies in Southern California and beyond. As part of the partnership, the companies announced the launch of OCTANe Shared Services (OSS) powered by RSM, a comprehensive shared services model designed to rapidly accelerate growth and enable organizations to scale efficiently.

MORE “RSM Announces Strategic Partnership with Technology and Life Sciences Accelerator, OCTANe”

FDA Approves Prior Approval Supplement for BIVIGAM®

RAMSEY, N.J. and BOCA RATON, Fla., May 10, 2019 — ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases, announces that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Prior Approval Supplement (“PAS”) for BIVIGAM® (immune globulin intravenous (human), 10% liquid).  The FDA’s approval of the PAS for BIVIGAM®approves the use of the Company’s optimized intravenous immune globulin (“IVIG”) manufacturing process and enables ADMA to commence the marketing of BIVIGAM® in the U.S. to patients with Primary Humoral Immunodeficiency (“PI”).

MORE “FDA Approves Prior Approval Supplement for BIVIGAM®”

Cytonics Announces Letter of Intent to Extend the APIC Sales Agreement and Enter International and Veterinary Markets

Cytonics Corporation and Sygenx, Inc. have signed a Letter of Intent to assign Sygenx an exclusive license to manufacture and sell the APIC system in the international and domestic markets. Sygenx’s distribution arm, Catalyst Sales & Marketing, was recently acquired by CareStream America, a Canadian-based international distributor of medical devices with a sales force of over 50 domestic sales reps.

MORE “Cytonics Announces Letter of Intent to Extend the APIC Sales Agreement and Enter International and Veterinary Markets”

Dyadic Announces Sub-Licensing Agreement with Alphazyme

JUPITER, FL / May 6, 2019 / Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs and other biologic products at flexible commercial scales, is pleased to announce a sub-licensing agreement entered into with Alphazyme LLC (“Alphazyme”), a biotech company focused on producing molecular biology enzymes addressing markets for custom DNA and RNA molecules, genomic medicines and genetic testing.

MORE “Dyadic Announces Sub-Licensing Agreement with Alphazyme”